Lyra Therapeutics Inc (LYRA) is around the top of the Biotechnology industry according to InvestorsObserver. LYRA received an overall rating of 75, which means that it scores higher than 75 percent of all stocks. Lyra Therapeutics Inc also achieved a score of 95 in the Biotechnology industry, putting it above 95 percent of Biotechnology stocks. Biotechnology is ranked 66 out of the 148 industries.
LYRA has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on LYRA!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 75 would rank higher than 75 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Lyra Therapeutics Inc Stock Today?
Lyra Therapeutics Inc (LYRA) stock is trading at $4.69 as of 12:28 PM on Wednesday, Sep 13, a gain of $0.09, or 1.96% from the previous closing price of $4.60. The stock has traded between $4.45 and $4.89 so far today. Volume today is light. So far 311,883 shares have traded compared to average volume of 441,282 shares.
Click Here to get the full Stock Report for Lyra Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
